Cart
sales@molnova.com
Hypocrellin A
CAS No. 77029-83-5
Hypocrellin A( —— )
Catalog No. M20488 CAS No. 77029-83-5
Hypocrellin A is PKC inhibitor has light-induced antitumorantifungal and antiviral activities it also exerts immunomodulatory effects on MHC-restricted presentation of antigen.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 116 | In Stock |
|
| 10MG | 187 | In Stock |
|
| 25MG | 377 | In Stock |
|
| 50MG | 541 | In Stock |
|
| 100MG | 771 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 1544 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameHypocrellin A
-
NoteResearch use only, not for human use.
-
Brief DescriptionHypocrellin A is PKC inhibitor has light-induced antitumorantifungal and antiviral activities it also exerts immunomodulatory effects on MHC-restricted presentation of antigen.
-
DescriptionHypocrellin A is PKC inhibitor has light-induced antitumorantifungal and antiviral activities it also exerts immunomodulatory effects on MHC-restricted presentation of antigen.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetPKC
-
RecptorPKC
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number77029-83-5
-
Formula Weight546.52
-
Molecular FormulaC30H26O10
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 16.67 mg/mL (30.50 mM)
-
SMILESCOc1cc(=O)c2c(O)c(OC)c3C[C@](C)(O)[C@H](C(C)=O)c4c(OC)c(O)c5c6c(c(OC)cc5=O)c1c2c3c46
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Wang L Wang J Cao Y et al. Molecular evidence for better efficacy of hypocrellin A and oleanolic acid combination in suppression of HCC growth[J]. European Journal of Pharmacology 2018.
molnova catalog
related products
-
ZIP
Novel, cell-permeable inhibitor of protein kinase Mζ (PKMζ), a constitutively active, atypical PKC isozyme involved in LTP maintenance. Selectively blocks PKMζ-induced synaptic potentiation in hippocampal slices in vitro. Reverses late-phase LTP (IC50 = 1 - 2.5 μM) and produces persistent loss of 1-day-old spatial memory following central administration in vivo.
-
CGP-53353
CGP-53353 (DAPH-7) is a selective inhibitor of PKCβII with IC50 of 0.41 uM, shows weak activity on PKCβI with IC50 of 3.8 uM.
-
LY379196
LY379196 is a highly specific PKCβ inhibitor with IC50 of 30-50 nM for PKCβI and PKCβII.
